312 related articles for article (PubMed ID: 28580628)
1. Mortality in the Waikato Hospital Systemic Sclerosis Cohort.
Ooi C; Solanki K; Lao C; Frampton C; White D
Int J Rheum Dis; 2018 Jan; 21(1):253-260. PubMed ID: 28580628
[TBL] [Abstract][Full Text] [Related]
2. The effect of male sex on survival in systemic sclerosis.
Hussein H; Lee P; Chau C; Johnson SR
J Rheumatol; 2014 Nov; 41(11):2193-200. PubMed ID: 25274896
[TBL] [Abstract][Full Text] [Related]
3. Early Mortality in a Multinational Systemic Sclerosis Inception Cohort.
Hao Y; Hudson M; Baron M; Carreira P; Stevens W; Rabusa C; Tatibouet S; Carmona L; Joven BE; Huq M; Proudman S; Nikpour M; ;
Arthritis Rheumatol; 2017 May; 69(5):1067-1077. PubMed ID: 28029745
[TBL] [Abstract][Full Text] [Related]
4. Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease.
Mathai SC; Hummers LK; Champion HC; Wigley FM; Zaiman A; Hassoun PM; Girgis RE
Arthritis Rheum; 2009 Feb; 60(2):569-77. PubMed ID: 19180517
[TBL] [Abstract][Full Text] [Related]
5. Mortality and hospitalization outcomes of interstitial lung disease and pulmonary hypertension in the Singapore systemic sclerosis cohort.
Noviani M; Saffari SE; Tan JL; Yip JWL; Teng GG; Law WG; Chan GYL; Santosa A; Lim AYN; Hong C; Ng SA; Tay ELW; Ruan W; Yap J; Low AHL
Semin Arthritis Rheum; 2020 Jun; 50(3):473-479. PubMed ID: 31810742
[TBL] [Abstract][Full Text] [Related]
6. Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary arterial hypertension without affecting hemodynamics and exercise capacity.
Michelfelder M; Becker M; Riedlinger A; Siegert E; Drömann D; Yu X; Petersen F; Riemekasten G
Clin Rheumatol; 2017 Feb; 36(2):381-390. PubMed ID: 28028682
[TBL] [Abstract][Full Text] [Related]
7. Sex disparities in systemic sclerosis-associated pulmonary arterial hypertension: a cohort study.
Pasarikovski CR; Granton JT; Roos AM; Sadeghi S; Kron AT; Thenganatt J; Moric J; Chau C; Johnson SR
Arthritis Res Ther; 2016 Jan; 18():30. PubMed ID: 26819137
[TBL] [Abstract][Full Text] [Related]
8. Survival after lung transplantation in systemic sclerosis. A systematic review.
Khan IY; Singer LG; de Perrot M; Granton JT; Keshavjee S; Chau C; Kron A; Johnson SR
Respir Med; 2013 Dec; 107(12):2081-7. PubMed ID: 24113572
[TBL] [Abstract][Full Text] [Related]
9. Determinants of morbidity and mortality of systemic sclerosis in Canada.
Al-Dhaher FF; Pope JE; Ouimet JM
Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
[TBL] [Abstract][Full Text] [Related]
10. Improved transplant-free survival in patients with systemic sclerosis-associated pulmonary hypertension and interstitial lung disease.
Volkmann ER; Saggar R; Khanna D; Torres B; Flora A; Yoder L; Clements PJ; Elashoff RM; Ross DJ; Agrawal H; Borazan N; Furst DE; Saggar R
Arthritis Rheumatol; 2014 Jul; 66(7):1900-8. PubMed ID: 24729406
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors of mortality and 2-year survival analysis of systemic sclerosis with pulmonary arterial hypertension in Thailand.
Foocharoen C; Nanagara R; Kiatchoosakun S; Suwannaroj S; Mahakkanukrauh A
Int J Rheum Dis; 2011 Aug; 14(3):282-9. PubMed ID: 21816025
[TBL] [Abstract][Full Text] [Related]
12. All-cause Healthcare Costs and Mortality in Patients with Systemic Sclerosis with Lung Involvement.
Fischer A; Kong AM; Swigris JJ; Cole AL; Raimundo K
J Rheumatol; 2018 Feb; 45(2):235-241. PubMed ID: 29142033
[TBL] [Abstract][Full Text] [Related]
13. Assessing Mortality Models in Systemic Sclerosis-Related Interstitial Lung Disease.
Mango RL; Matteson EL; Crowson CS; Ryu JH; Makol A
Lung; 2018 Aug; 196(4):409-416. PubMed ID: 29785507
[TBL] [Abstract][Full Text] [Related]
14. Survival and causes of death in an unselected and complete cohort of Norwegian patients with systemic sclerosis.
Hoffmann-Vold AM; Molberg Ø; Midtvedt Ø; Garen T; Gran JT
J Rheumatol; 2013 Jul; 40(7):1127-33. PubMed ID: 23637316
[TBL] [Abstract][Full Text] [Related]
15. Survival rate, causes of death, and risk factors in systemic sclerosis: a large cohort study.
Li X; Qian YQ; Liu N; Mu R; Zuo Y; Wang GC; Jia Y; Li ZG
Clin Rheumatol; 2018 Nov; 37(11):3051-3056. PubMed ID: 30225558
[TBL] [Abstract][Full Text] [Related]
16. [Survival and death causes in 251 systemic sclerosis patients from a single Italian center].
Vettori S; Cuomo G; Abignano G; Iudici M; Valentini G
Reumatismo; 2010; 62(3):202-9. PubMed ID: 21052567
[TBL] [Abstract][Full Text] [Related]
17. Prevalence, Treatment, and Outcomes of Coexistent Pulmonary Hypertension and Interstitial Lung Disease in Systemic Sclerosis.
Young A; Vummidi D; Visovatti S; Homer K; Wilhalme H; White ES; Flaherty K; McLaughlin V; Khanna D
Arthritis Rheumatol; 2019 Aug; 71(8):1339-1349. PubMed ID: 30762947
[TBL] [Abstract][Full Text] [Related]
18. Prognostic profile of systemic sclerosis: analysis of the clinical EUSTAR cohort in China.
Hu S; Hou Y; Wang Q; Li M; Xu D; Zeng X
Arthritis Res Ther; 2018 Oct; 20(1):235. PubMed ID: 30348207
[TBL] [Abstract][Full Text] [Related]
19. Malnutrition is an independent risk factor for mortality in Mexican patients with systemic sclerosis: a cohort study.
Cruz-Domínguez MP; García-Collinot G; Saavedra MA; Montes-Cortes DH; Morales-Aguilar R; Carranza-Muleiro RA; Vera-Lastra OL; Jara LJ
Rheumatol Int; 2017 Jul; 37(7):1101-1109. PubMed ID: 28555363
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary Artery Dimensions as a Prognosticator of Transplant-Free Survival in Scleroderma Interstitial Lung Disease.
Gleason JB; Patel KB; Hernandez F; Hadeh A; Highland KB; Rahaghi F; Mehta JP
Lung; 2017 Aug; 195(4):403-409. PubMed ID: 28456874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
